Perspective Therapeutics, Inc. (CATX)
5.65
0.00 (0.00%)
USD |
NYAM |
Feb 20, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics EPS Diluted (Quarterly) : -0.3495 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.97M |
| Revenue (Quarterly) | 0.209M |
| Total Expenses (Quarterly) | 26.18M |
| Enterprise Value | 472.79M |
| Gross Profit Margin (Quarterly) | -270.8% |
| Profit Margin (Quarterly) | -12.43K% |
| Earnings Yield | -25.81% |
| Normalized Earnings Yield | -21.60 |